2024-09-22 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co is a multinational consumer products company that manufactures and sells personal care, home care, and pet nutrition products. 

**1. Performance Comparison:**

Colgate-Palmolive's cumulative return of 44.71% significantly lags behind the S&P 500 (VOO) with a cumulative return of 132.46%. This difference is reflected in the relative divergence, which stands at -87.75, indicating that Colgate-Palmolive's performance is 87.75% below the S&P 500 over the historical period. 

**2. Recent Price Movement:**

* **Closing Price:** $103.06
* **5-day Moving Average:** $103.77
* **20-day Moving Average:** $105.86
* **60-day Moving Average:** $101.62

The price is currently below its 5-day, 20-day, and 60-day moving averages, suggesting a potential downward trend.

**3. Technical Indicators:**

* **RSI (Relative Strength Index):** 31.64
* **PPO (Percentage Price Oscillator):** -0.71
* **Delta_Previous_Relative_Divergence:** -6.29 (Short-term downtrend)
* **Expected Return:** 4.72% (5-year projected return)

The RSI suggests that the stock is currently in oversold territory. The negative PPO indicates a weakening price momentum. The negative Delta_Previous_Relative_Divergence signals a short-term downtrend. However, the Expected Return suggests potential upside potential over the long term. 

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-26 | 0.89 | 5.06 B$ |
| 2024-04-26 | 0.83 | 5.07 B$ |
| 2023-10-27 | 0.86 | 4.92 B$ |
| 2023-07-28 | 0.61 | 4.82 B$ |
| 2024-07-26 | 0.61 | 4.82 B$ |

The most recent earnings report for Q2 2024 showed EPS of $0.89, slightly exceeding analysts' expectations. Revenue also beat expectations, reaching $5.06 billion. The company demonstrated consistent growth in revenue, but earnings have been volatile in recent quarters.

**5. Overall Analysis:**

Colgate-Palmolive's performance has lagged behind the S&P 500 significantly, with a lower cumulative return and negative relative divergence.  However, the recent earnings results showed a beat on both EPS and revenue, suggesting potential for improvement. The technical indicators are mixed, with oversold conditions and a negative short-term trend, but a positive expected return over the long term. Further monitoring of price action and earnings reports will be crucial for determining future investment strategy.

**6. Recommendations:**

While the current situation appears challenging for Colgate-Palmolive, the strong brand recognition, consistent revenue growth, and positive earnings beat in Q2 2024 offer some optimism. Investors may consider waiting for further price action confirmation and assessing future earnings reports before making any significant investment decisions. Long-term investors with a higher risk tolerance might consider adding this stock to their portfolio for the potential long-term growth it offers. 
